Literature DB >> 22483456

Long-term risk of hypertension and chronic kidney disease in living kidney donors.

S H Kim1, H S Hwang, H E Yoon, Y K Kim, B S Choi, I S Moon, J C Kim, T K Hwang, Y S Kim, C W Yang.   

Abstract

OBJECTIVE: The aim of this study was to assess the long-term risks of chronic kidney disease and arterial hypertension in living kidney donors.
METHODS: Donors who were followed for more than 1 year after nephrectomy were included. We assessed each donor's blood pressure, urine protein, and estimated glomerular filtration rate (eGFR).
RESULTS: The follow-up rate was 11% (154 out of 1,356 donors), only 19% of whom were followed by nephrologists. Blood pressure had increased from 113/75 to 116/77 mm Hg (P < .01), urinary protein excretion after donation did not increase, and renal function was well preserved after donor nephrectomy. However, 33 patients (21.4%) showed a decreased eGFR of <60 mL/min/1.73 m(2), and 3 donors developed end-stage renal disease that required renal replacement therapy.
CONCLUSIONS: The follow-up rate of living donors after donation was low, and we observed an increased risk of developing chronic kidney disease after donation.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22483456     DOI: 10.1016/j.transproceed.2011.12.066

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  10 in total

1.  Quantifying Postdonation Risk of ESRD in Living Kidney Donors.

Authors:  Allan B Massie; Abimereki D Muzaale; Xun Luo; Eric K H Chow; Jayme E Locke; Anh Q Nguyen; Macey L Henderson; Jon J Snyder; Dorry L Segev
Journal:  J Am Soc Nephrol       Date:  2017-04-27       Impact factor: 10.121

Review 2.  Long-term outcomes of laparoscopic versus open donor nephrectomy for kidney transplantation: a meta-analysis.

Authors:  Lingping Wang; Li Zhu; Xubiao Xie; Haifeng Wang; Hui Yin; Chunhua Fang; Helong Dai
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

Review 3.  Long-term medical risks to the living kidney donor.

Authors:  Ngan N Lam; Krista L Lentine; Andrew S Levey; Bertram L Kasiske; Amit X Garg
Journal:  Nat Rev Nephrol       Date:  2015-05-05       Impact factor: 28.314

4.  Living kidney donation in a developing country.

Authors:  Chandni Dayal; Malcolm Davies; Nina Elisabeth Diana; Anthony Meyers
Journal:  PLoS One       Date:  2022-05-10       Impact factor: 3.752

5.  Validation of Living Donor Nephrectomy Codes.

Authors:  Ngan N Lam; Krista L Lentine; Scott Klarenbach; Manish M Sood; Paul J Kuwornu; Kyla L Naylor; Gregory A Knoll; S Joseph Kim; Ann Young; Amit X Garg
Journal:  Can J Kidney Health Dis       Date:  2018-04-09

Review 6.  Chronic kidney disease as a cardiovascular risk factor: lessons from kidney donors.

Authors:  Anna M Price; Nicola C Edwards; Manvir K Hayer; William E Moody; Richard P Steeds; Charles J Ferro; Jonathan N Townend
Journal:  J Am Soc Hypertens       Date:  2018-05-09

7.  Blood Pressure and Living Kidney Donors: A Clinical Perspective.

Authors:  Anjay Rastogi; Stanley Yuan; Farid Arman; Lewis Simon; Kelly Shaffer; Mohammad Kamgar; Niloofar Nobakht; Jonathan S Bromberg; Matthew R Weir
Journal:  Transplant Direct       Date:  2019-09-19

8.  Effects of living kidney donation on arterial stiffness: a systematic review protocol.

Authors:  Rosendo A Rodriguez; Mayra Trentin Sonoda; Mohsen Agharazii; Risa Shorr; Kevin D Burns
Journal:  BMJ Open       Date:  2021-03-08       Impact factor: 2.692

Review 9.  Risk for subsequent hypertension and cardiovascular disease after living kidney donation: is it clinically relevant?

Authors:  Charles J Ferro; Jonathan N Townend
Journal:  Clin Kidney J       Date:  2021-12-13

10.  Changes in Blood Pressure and Arterial Hemodynamics following Living Kidney Donation.

Authors:  Anna M Price; George H B Greenhall; William E Moody; Richard P Steeds; Patrick B Mark; Nicola C Edwards; Manvir K Hayer; Luke C Pickup; Ashwin Radhakrishnan; Jonathan P Law; Debasish Banerjee; Tunde Campbell; Charles R V Tomson; John R Cockcroft; Badri Shrestha; Ian B Wilkinson; Laurie A Tomlinson; Charles J Ferro; Jonathan N Townend
Journal:  Clin J Am Soc Nephrol       Date:  2020-08-25       Impact factor: 8.237

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.